2024 Acetaminophen causes neurodevelopmental injury in susceptible babies and children: no valid rationale for controversy Corresponding author: William Parker, PhD, WPLab, Inc., 2608 Erwin Rd., STE 148-155, Durham, NC 27705, USA Email: [email protected] Received November 2, 2022 Revised February 10, 2023 Accepted May 4, 2023 Abstract Despite the worldwide acceptance of acetaminophen (APAP) as a necessary medicine in pediatrics, evidence that early exposure to APAP causes neurodevelopmental injury in susceptible babies and children has been mounting for over a decade
In children 12 to 17 years of age with obesity, the percentage of patients with a reduction of greater than or equal to 10% of their BMI was 33.5% (taking the 7.5 mg/46 mg dose) and 44.4% (taking the 15 mg/92 mg dose) compared to 4.5% of those taking a placebo
Its not as good as the diabetic data, partially because its a much larger trial and partially because diabetics just seem to tolerate these medications better
Connective Tissue and Musculoskeletal Research One of the most extensively published research areas involves this peptide in the context of connective tissue biology
no new drug application for CJC-1295 has ever been completed
